Catalani V - Search Results

1

New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review.

Schifano F, Chiappini S, Miuli A, Corkery JM, Scherbaum N, Napoletano F, Arillotta D, Zangani C, Catalani V, Vento A, Pettorruso M, Martinotti G, Massimo DG, Guirguis A. Schifano F, et al. Among authors: catalani v. Exp Neurol. 2021 May;339:113638. doi: 10.1016/j.expneurol.2021.113638. Epub 2021 Feb 8. Exp Neurol. 2021. PMID: 33571533

2

Octodrine: New Questions and Challenges in Sport Supplements.

Catalani V, Prilutskaya M, Al-Imam A, Marrinan S, Elgharably Y, Zloh M, Martinotti G, Chilcott R, Corazza O. Catalani V, et al. Brain Sci. 2018 Feb 20;8(2):34. doi: 10.3390/brainsci8020034. Brain Sci. 2018. PMID: 29461475 Free PMC article.

3

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach.

Catalani V, Arillotta D, Corkery JM, Guirguis A, Vento A, Schifano F. Catalani V, et al. Front Psychiatry. 2021 Feb 9;11:632405. doi: 10.3389/fpsyt.2020.632405. eCollection 2020. Front Psychiatry. 2021. PMID: 33633599 Free PMC article.

4

Psychonauts' psychedelics: A systematic, multilingual, web-crawling exercise.

Catalani V, Corkery JM, Guirguis A, Napoletano F, Arillotta D, Zangani C, Vento A, Schifano F. Catalani V, et al. Eur Neuropsychopharmacol. 2021 Aug;49:69-92. doi: 10.1016/j.euroneuro.2021.03.006. Epub 2021 Apr 12. Eur Neuropsychopharmacol. 2021. PMID: 33857740

5

The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity.

Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Scherbaum N, Schifano F. Catalani V, et al. Pharmaceuticals (Basel). 2021 Jul 26;14(8):720. doi: 10.3390/ph14080720. Pharmaceuticals (Basel). 2021. PMID: 34451817 Free PMC article.

6

Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.

Schifano F, Catalani V, Sharif S, Napoletano F, Corkery JM, Arillotta D, Fergus S, Vento A, Guirguis A. Schifano F, et al. Among authors: catalani v. Drugs. 2022 Apr;82(6):633-647. doi: 10.1007/s40265-022-01701-7. Epub 2022 Apr 2. Drugs. 2022. PMID: 35366192 Review.

7

Correction to: Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.

Schifano F, Catalani V, Sharif S, Napoletano F, Corkery JM, Arillotta D, Fergus S, Vento A, Guirguis A. Schifano F, et al. Among authors: catalani v. Drugs. 2022 May;82(7):839. doi: 10.1007/s40265-022-01716-0. Drugs. 2022. PMID: 35476318 No abstract available.

8

Designer Benzodiazepines' Activity on Opioid Receptors: A Docking Study.

Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Schifano F. Catalani V, et al. Curr Pharm Des. 2022;28(32):2639-2652. doi: 10.2174/1381612828666220510153319. Curr Pharm Des. 2022. PMID: 35538798

9

In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines.

Catalani V, Floresta G, Botha M, Corkery JM, Guirguis A, Vento A, Abbate V, Schifano F. Catalani V, et al. Chem Biol Drug Des. 2023 Jan;101(1):40-51. doi: 10.1111/cbdd.14119. Epub 2022 Sep 5. Chem Biol Drug Des. 2023. PMID: 35838189

10

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach.

Arillotta D, Floresta G, Guirguis A, Corkery JM, Catalani V, Martinotti G, Sensi SL, Schifano F. Arillotta D, et al. Among authors: catalani v. Brain Sci. 2023 Oct 24;13(11):1503. doi: 10.3390/brainsci13111503. Brain Sci. 2023. PMID: 38002464 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters